Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.

Resource Library

2012 Neonatal and Childhood Pulmonary Vascular Disease Conference Presentations

Through a partnership with UCSF, PHA is able to present the recordings of their 5th Annual Neonatal and Childhood Pulmonary Vascular Disease Conference, which was held in San Francisco, CA.

Learn more about the upcoming 2013 conference. 

  1. Welcome and Opening Comments
    Jeffrey Fineman, MD 
  2. Alveolar Capillary Dysplasia
    Robin Steinhorn, MD
  3. Assessment and Management of Pulmonary Hypertensive Disease Complicating ARDS and Intercurrent or Non-Cardiac Illness
    Desmond Bohn, MD, MB, FRCPC
  4. Epidemiology of Pediatric and Neonatal Pulmonary Vascular Disease in the Netherlands
    R. M. F. Berger, MD
  5. Evaluation and Treatment of Low Cardiac Output Due to Right Ventricular Dysfunction and Cardiopulmonary Interactions
    Andrew Redington, MD
  6. Experimental Rationale for New and Emerging Therapies of Pulmonary Hypertensive Vascular Disease: What’s on the Horizon
    Stephen Archer, MD
  7. Fetal Conditions Associated with Lung Hypoplasia, Etiology and Outcomes
    Greg Ryan, MD
  8. Inhaled Therapy in Pediatric PH
    Dunbar Ivy, MD
  9. Initial Evaluation of the Child with PAH From a Nursing Persepective
    Michelle Ogawa, CPNP
  10. IV Therapies for Pulmonary Hypertensive Vascular Disease
    Erika Berman Rosenzweig, MD on behalf of Robin J. Barst, MD
  11. Late Effects of Neonatal Lung Injury
    Kurt Albertine, PhD
  12. Lung Biopsy in the Diagnosis of Pulmonary Hypertensive Vascular Disease in Neonates and Infants
    Rubin Tuder, MD
  13. Neonatal Respiratory Distress: Where are we going? 
    Neil Finer, MD
  14. Novel Approaches to the Evaluation of Pulmonary Vascular Disease
    Marilyne Levy, MD, PhD
  15. Oral Therapies for Children with Pulmonary Hypertensive Vascular Disease
    Erika Berman Rosenzweig, MD
  16. Prenatal Predictors of Postnatal Lung Hypoplasia: Ultrasound and Echo
    Jan Deprest, MD
  17. Prenatal Predictors of Postnatal Lung Hypoplasia: MRI Assessment
    Ravi Bhargava, MD, FRCPC
  18. Pulmonary Stem Cell Populations: Therapeutic Implications 
    Kurt Stenmark, MD
  19. Pulmonary Vasodilator Treatments in the ICU Setting
    Lara Shekerdemian, MD
  20. Pulmonary Veno-Occlusive Disease and Pulmonary Capillary Hemangiomatosis: Clinical Presentation, Pathology, and Treatment
    Mary Mullen, MD, PhD
  21. Special Anesthetic Considerations in the Assessment and Management of the Child with Pulmonary Hypertensive Vascular Disease
    Chandra Ramamoorthy, MD, MBBS, FRCA
  22. Subcutaneous Treprostinil: Practical Aspects to Ensure Success
    Darcy Farrell, RN, BScN
  23. Surgical Approaches to Advanced Pulmonary Vascular Disease
    William Novick, MD, MS
  24. The Effective Treatment of Patients with Pulmonary Hypertension: The Next Chapter
    Stuart Rich, MD
  25. The Role of Balloon Atrial Septostomy in the management of Childhood Pulmonary Hypertensive Vascular Disease
    Ingram Schulze-Neick, MD
  26. Therapeutic Implications of Endothelial Progenitor Cells in Bronchopulmonary Dysplasia
    Shawn Ahlfeld, MD
  27. Understanding the Vasculature in Pulmonary Atresia, Ventricular Septal Defect, and Aortopulmonary Collaterals
    Frank Hanley, MD
  28. Vasoactivity of Circulating NO Species
    Arlin Blood, MD
  29. Wrap Up and Closing Comments
    Ian Adatia, MD 


  Sign in to add a review